Heptaminol

DB13574InvestigationalSmall molecule

Heptaminol is a cardiac stimulant and vasodilator indicated in the treatment of hemorrhoids and venolymphatic insufficiency. A medication used to treat hemorrhoids and poor blood flow in the legs.

Chemical structure of Heptaminol
Mechanism
Curator reviewed
Formula / weight
C8H19NO · 145.246 g/mol (avg)

Resolves to

Compound
UNII3DQS188SY5CAS372-66-7ChEMBLCHEMBL2111076ChEBI94362
Clinical / RWD
RxNorm5254ATCC01DX08
Structure
InChIKeyLREQLEBVOXIEOM-UHFFFAOYSA-NSMILESCC(N)CCCC(C)(C)O
Targets
P23975SLC6A2

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
3Marketed productsAcross 3 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 5 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Heptaminol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In